Status:
ACTIVE_NOT_RECRUITING
Ventricular Tachycardia Ablation Through Radiation Therapy Consortium: Concept Description of an Observational Retrospective Multicentric Trial
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Ventricular Tachycardia (VT)
Eligibility:
All Genders
18+ years
Brief Summary
Recurrent ventricular tachycardia (VT) is a potentially life-threatening arrhythmia in patients with structural heart disease. Despite the use of antiarrhythmic drugs, implantable cardioverter-defibri...
Eligibility Criteria
Inclusion
- Diagnosis of refractory ventricular tachycardia (VT), as previously defined
- Age greater than 18 years
- Presence of an implantable cardioverter-defibrillator (ICD) for follow-up
- Not eligible for heart transplantation
- Estimated life expectancy of at least 1 year
- Ability to provide autonomous, informed consent to participate in the study
Exclusion
- ICD interrogation demonstrating polymorphic VT
- Patients with INTERMACS class more than 4
- Patients with LVADs
- Patients with active neoplastic disease under oncological treatment
Key Trial Info
Start Date :
March 30 2025
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 30 2029
Estimated Enrollment :
149 Patients enrolled
Trial Details
Trial ID
NCT06990139
Start Date
March 30 2025
End Date
March 30 2029
Last Update
May 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo Francesco Vito 1, 00168, Rome (Italy)
Rome, ROME, Italy, 00168